Skip to main content
    K

    Kalaris Therapeutics, Inc. (KLRS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.46
    -0.12 (-7.30%)

    Market Cap: $37.49M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Kalaris Therapeutics, Inc. (KLRS) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Kalaris Therapeutics (KLRS) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Kalaris Therapeutics reported EPS of -$0.46, above the -$0.52 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    30%(8/27)
    Avg Surprise
    -32.33%
    Streak
    4 Q

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.52
    Range-$0.56 - -$0.49
    10 analysts
    Revenue Consensus
    N/A
    RangeN/A
    9 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.59
    Range-$0.66 - -$0.53
    5 analysts
    EPS Revisions
    3
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.55-6.9%
    60d ago-$0.55-6.9%
    30d ago-$0.55-6.9%
    7d ago-$0.55-6.9%
    Current-$0.59
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    KLRS has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 27 quarters below that had an estimate, KLRS beat 8, missed 5 and matched 14. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 765.58% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.46-$0.52-$0.57 - -$0.40+11.54%BeatN/A84 up, 2 downNov 10, 2026
    Jun 30, 2026-$0.48-$0.50-$0.55 - -$0.38+4.00%BeatN/A81 up, 0 downAug 11, 2026
    Mar 31, 2026-$0.46-$0.52-$0.61 - -$0.43+11.54%BeatN/A63 up, 0 downMay 12, 2026
    Dec 31, 2025-$0.44-$0.55-$0.73 - -$0.17+20.00%BeatN/A62 up, 0 downMar 17, 2026
    Sep 30, 2025-$0.64-$0.61-$1.81 - -$0.60-4.92%MissN/A20 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.61-$0.52N/A-17.31%MissN/A20 up, 1 downAug 13, 2025
    Mar 31, 2025-$2.52-$0.77N/A-227.27%MissN/AN/AN/AMay 14, 2025
    Dec 31, 2024-$3.28-$2.76N/A-18.90%MissN/AN/AN/AMar 7, 2025
    Sep 30, 2024-$0.82-$0.10N/A-765.58%MissN/AN/AN/ANov 12, 2024
    Jun 30, 2024-$0.05-$0.05N/A0.00%In lineN/AN/AN/AAug 1, 2024
    Mar 31, 2024-$0.26-$0.26N/A0.00%In lineN/AN/AN/AMay 2, 2024
    Dec 31, 2023-$0.52-$0.52N/A0.00%In lineN/AN/AN/AFeb 8, 2024
    Sep 30, 2023-$0.39-$0.39N/A0.00%In lineN/AN/AN/ANov 2, 2023
    Jun 30, 2023-$0.48-$0.48N/A0.00%In lineN/AN/AN/AAug 3, 2023
    Mar 31, 2023-$0.44-$0.47N/A+6.38%BeatN/AN/AN/AJun 29, 2023
    Dec 31, 2022-$0.32-$0.32N/A0.00%In lineN/AN/AN/AMar 30, 2023
    Sep 30, 2022-$0.50-$0.50N/A0.00%In lineN/AN/AN/ANov 3, 2022
    Jun 30, 2022-$0.69-$0.69N/A0.00%In lineN/AN/AN/AAug 4, 2022
    Mar 31, 2022-$0.69-$0.69N/A0.00%In lineN/AN/AN/AJun 29, 2022
    Dec 31, 2021-$0.92-$0.92N/A0.00%In lineN/AN/AN/AMar 30, 2022
    Sep 30, 2021-$0.72-$0.72N/A0.00%In lineN/AN/AN/ANov 5, 2021
    Jun 30, 2021-$0.60-$0.60N/A0.00%In lineN/AN/AN/AAug 6, 2021
    Mar 31, 2021-$0.50-$0.50N/A0.00%In lineN/AN/AN/AJun 29, 2021
    Dec 31, 2020-$0.41-$0.44N/A+6.82%BeatN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$0.58-$0.58N/A0.00%In lineN/AN/AN/ANov 10, 2020
    Jun 30, 2020-$0.34-$4.43N/A+92.33%BeatN/AN/AN/AJul 6, 2020
    Mar 31, 2020-$4.21-$4.60N/A+8.43%BeatN/AN/AN/AJun 29, 2020
    Last 27 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.21, after -$4.41 the year before. It was -$5.54 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.21N/A
    Dec 31, 2024-$4.41N/A
    Dec 31, 2023-$1.83N/A
    Dec 31, 2022-$2.20N/A
    Dec 31, 2021-$2.74N/A
    Dec 31, 2020-$5.54N/A

    Frequently Asked Questions About KLRS

    When is Kalaris Therapeutics's next earnings date?

    Kalaris Therapeutics's next earnings report is expected for Mar 15, 2027.

    Did KLRS beat earnings estimates last quarter?

    Yes. Kalaris Therapeutics reported EPS of -$0.46 for the quarter ended Sep 30, 2026, above the -$0.52 estimate, a 11.54% surprise.

    What EPS do analysts expect from KLRS next quarter?

    The consensus EPS estimate for Kalaris Therapeutics for the quarter ending Dec 31, 2026 is -$0.52 from 10 analysts, with estimates from -$0.56 to -$0.49.

    How often does KLRS beat earnings estimates?

    Kalaris Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -27.67%.